Showing Results for
- Academic Journals (9)
Search Results
- 9
Academic Journals
- 9
- Search Terms:
- 1From: The Pharmacogenomics Journal. (Vol. 6, Issue 4) Peer-ReviewedAuthor(s): S RodrÃguez-Nóvoa [1]; P Barreiro [2]; I Jiménez-Nácher [1]; V Soriano [2] Since the approval of the first antiretroviral drug, azidothymidine (AZT) in 1987, more than 20 drugs have been approved for the...
- 2From: The Pharmacogenomics Journal. (Vol. 6, Issue 4) Peer-ReviewedAuthor(s): J Reischl [1]; M Schröder [2]; N Luttenberger [3]; D Petrov [2]; B Schümann [3]; R Ternes [1]; S Stürzebecher [1] Pharmacogenetic research has been considered a special form of genetics and, therefore,...
- 3From: The Pharmacogenomics Journal. (Vol. 6, Issue 4) Peer-ReviewedAuthor(s): C Lonjou [1]; L Thomas [2]; N Borot [1]; N Ledger [1]; C de Toma [3]; H LeLouet [4]; E Graf [5]; M Schumacher [5]; A Hovnanian [1]; M Mockenhaupt [6]; J-C Roujeau [2]; (for the RegiSCAR group)...
- 4From: The Pharmacogenomics Journal. (Vol. 6, Issue 4) Peer-ReviewedAuthor(s): L Anfosso [1]; T Efferth [2]; A Albini [1]; U Pfeffer [3] Surgery, chemotherapy and radiotherapy have been the established treatment options for cancer during the past five decades. They aim to damage...
- 5From: The Pharmacogenomics Journal. (Vol. 6, Issue 4) Peer-ReviewedAuthor(s): Z Wei [1]; D D Mousseau [1]; Y Dai [1]; X Cao [1]; X-M Li [1] Haloperidol (HAL) is a typical antipsychotic still used in the treatment of many mental health issues worldwide, including predominantly for...
- 6From: The Pharmacogenomics Journal. (Vol. 6, Issue 4) Peer-ReviewedMild-to-moderate AD patients were randomized to placebo or rosiglitazone (RSG) 2, 4 or 8 mg. Primary end points at Week 24 were mean change from baseline in AD Assessment Scale-Cognitive (ADAS-Cog) and Clinician's...
- 7From: The Pharmacogenomics Journal. (Vol. 6, Issue 4) Peer-ReviewedFetal development is a period sensitive to environmental influences such as maternal drug use. The most commonly used illicit drug by pregnant women is marijuana. The present study investigated the effects of in utero...
- 8From: The Pharmacogenomics Journal. (Vol. 6, Issue 4) Peer-ReviewedData security The promise of personalized medicine is tempered by concerns about the security of pharmacogenomics data. In Reischl and co-workers' EELS paper (pp 225-233), they describe GENOMatch, Schering AG's...
- 9From: The Pharmacogenomics Journal. (Vol. 6, Issue 4) Peer-ReviewedAuthor(s): W Hsueh [1] Alzheimer's disease (AD), a progressive neural degeneration leading to deterioration in memory and comprehension, is increasing in prevalence as the elderly population grows in number. Few...